.Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G04B_Urologicals.G04BD13_Desfesoterodine.Desfesoterodine .Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G04B_Urologicals.G04BD13_Desfesoterodine.Desfesoterodine| name: | Desfesoterodine | |
| ATC code: | G04BD13 | |
| route: | oral | |
| compartments: | 2 | |
| dosage: | 8 | mg |
| volume of distribution: | 169 | L |
| clearance: | 15.6 | L/h |
| other parameters in model implementation | ||
Desfesoterodine is an active metabolite of fesoterodine, a muscarinic receptor antagonist used for the treatment of overactive bladder with symptoms of urinary incontinence, urgency, and frequency. It is not listed as an approved stand-alone drug as of 2024; its effects are clinically relevant as the active form resulting after fesoterodine administration.
Estimated pharmacokinetic parameters for desfesoterodine in healthy adult subjects, based on available data for the parent compound fesoterodine's active metabolite.